Clinical trial
Prescription Opioid Addiction Treatment Study (POATS)
NCT00316277 · Mclean Hospital, Other · Completed
Key facts
| NCT number | NCT00316277 |
|---|---|
| Title | Prescription Opioid Addiction Treatment Study (POATS) |
| Official title | A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Standard Medical Management or Enhanced Medical Management for Opioid Analgesic Dependence |
| Lead sponsor | Mclean Hospital, Other |
| Collaborators | University of California, Los Angeles |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Opiate Dependence, Substance-related Disorders, Opioid-related Disorders |
| Intervention type | Behavioral |
| Interventions | Standard Medical Management (SMM) of Prescription Opiate Abuse, Enhanced Medical Management (EMM) of Prescription Opiate Abuse |
| Enrollment | 653 |
| Start date | May 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Jan 1, 2013 |
| First posted | Apr 20, 2006 |
| Last update posted | Feb 6, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: